Fig. 9From: TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerIdentifying TFRC as prognosis marker for BLCA. A The position of TFRC in the chromosome. B The mutation frequency of the model genes. C TFRC expression levels of normal and tumor tissue in BLCA patients. D OS curves for BLCA patients with high and low TFRC expression. E The expression levels of TFRC in pan-cancerBack to article page